Table 1.
EV subtypes | Size range | Biogenesis | Isolation | Detection |
---|---|---|---|---|
Exosomes (Exo) (Théry et al., 2006, 2018; Raposo and Stoorvogel, 2013; Yáñez et al., 2015; Kowal et al., 2016; Willms et al., 2018; Jeppesen et al., 2019) | 30–100 nm | Release by exocytosis of multivesicular bodies (MVBs) | Differential centrifugation and density gradients (100,000–200,000 × g), immunoprecipitation, commercial kit, size exclusion chromatography | TEM, AFM, NTA, TRPS, DLS, WB, flow cytometry (bead coupled), ELISA |
Microvesicles (MVs) (Lötvall et al., 2014; Cocucci and Meldolesi, 2015; Kowal et al., 2016; Szatanek et al., 2017; Chiriacò et al., 2018; Crescitelli et al., 2020) | 100–1,000 nm | Direct budding of the cell membrane | Differential centrifugation (10,000–20,000 × g) Density gradients |
TEM, AFM, WB, flow cytometry (for vesicles >300 nm) |
Apoptotic bodies (Wickman et al., 2012; Atkin-Smith et al., 2015; Xu et al., 2019) | 500–5 μm | Outward blebbing and fragmentation of the cell membrane | Centrifugation, filtration | TEM, IF, flow cytometry |
TEM, transmission electron microscopy; AFM, atomic force microscope; NTA, nanoparticle tracking analysis; TRPS, tunable resistive pulse sensing; DLS, dynamic light scattering; IF, immunofluorescence microscopy; ELISA, enzyme-linked immunosorbent assay; WB, western blotting.